These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33738722)

  • 1. HPLC methods for choloroquine determination in biological samples and pharmaceutical products.
    Martins YA; Gonçalves TM; Lopez RFV
    Daru; 2021 Jun; 29(1):223-239. PubMed ID: 33738722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of anti-malaria agent chloroquine using single drop liquid-liquid-liquid microextraction.
    Daneshfar A; Khezeli T; Manafi MH
    J Sep Sci; 2009 Feb; 32(4):511-6. PubMed ID: 19173322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-mode gradient HPLC procedure for the simultaneous determination of chloroquine and proguanil.
    Paci A; Caire-Maurisier AM; Rieutord A; Brion F; Clair P
    J Pharm Biomed Anal; 2002 Jan; 27(1-2):1-7. PubMed ID: 11682204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPLC and HPTLC assays for the antimalarial agents chloroquine, primaquine and bulaquine.
    Dwivedi AK; Saxena D; Singh S
    J Pharm Biomed Anal; 2003 Nov; 33(4):851-8. PubMed ID: 14623615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of quinine and chloroquine anti-malarial agents in pharmaceuticals and biological fluids by HPLC and fluorescence detection.
    Samanidou VF; Evaggelopoulou EN; Papadoyannis IN
    J Pharm Biomed Anal; 2005 Jun; 38(1):21-8. PubMed ID: 15907614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chloroquine-N-oxide, a major oxidative degradation product of chloroquine: identification, synthesis and characterization.
    Doddaga S; Peddakonda R
    J Pharm Biomed Anal; 2013; 81-82():118-25. PubMed ID: 23644906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chirobiotic V Versus Chiralpak ID for the Enantioselective Chromatographic Separation of Chloroquine: Stability and Validation Study.
    Cardoso PA; Pereira DB; El-Behairy MF; Ghanem A; Pianetti GA; César IC
    J Chromatogr Sci; 2019 May; 57(5):443-450. PubMed ID: 30796784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous quantitation of chloroquine and primaquine by UPLC-DAD and comparison with a HPLC-DAD method.
    Miranda TA; Silva PH; Pianetti GA; César IC
    Malar J; 2015 Jan; 14():29. PubMed ID: 25626728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review.
    Plantone D; Koudriavtseva T
    Clin Drug Investig; 2018 Aug; 38(8):653-671. PubMed ID: 29737455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evaluation of marketed antimalarial chloroquine phosphate tablets.
    Patel AK; Prajapati BG; Moria RS; Patel CN
    J Vector Borne Dis; 2005 Dec; 42(4):147-50. PubMed ID: 16457384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of ELISA-based methods to measure the anti-malarial drug chloroquine in plasma and in pharmaceutical formulations.
    Khalil IF; Alifrangis M; Recke C; Hoegberg LC; Ronn A; Bygbjerg IC; Koch C
    Malar J; 2011 Aug; 10():249. PubMed ID: 21864375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Synthetic antimalarials].
    Fardet L; Revuz J
    Ann Dermatol Venereol; 2005; 132(8-9 Pt 1):665-74. PubMed ID: 16230916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.
    Rainsford KD; Parke AL; Clifford-Rashotte M; Kean WF
    Inflammopharmacology; 2015 Oct; 23(5):231-69. PubMed ID: 26246395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of quality of chloroquine tablets sold by drug vendors in Abeokuta, Nigeria.
    Idowu OA; Apalara SB; Lasisi AA
    Tanzan Health Res Bull; 2006 Jan; 8(1):45-6. PubMed ID: 17058801
    [No Abstract]   [Full Text] [Related]  

  • 15. Composition analysis of falsified chloroquine phosphate samples seized during the COVID-19 pandemic.
    Waffo Tchounga CA; Sacre PY; Ciza P; Ngono R; Ziemons E; Hubert P; Marini RD
    J Pharm Biomed Anal; 2021 Feb; 194():113761. PubMed ID: 33234414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. False chloroquine resistance in Africa.
    Basco LK; Ringwald P; Manéné AB; Chandenier J
    Lancet; 1997 Jul; 350(9072):224. PubMed ID: 9250219
    [No Abstract]   [Full Text] [Related]  

  • 17. Chloroquine in the Ugandan market fails quality test: a pharmacovigilance study.
    Ogwal-Okeng JW; Owino E; Obua C
    Afr Health Sci; 2003 Apr; 3(1):2-6. PubMed ID: 12789081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic monitoring of chloroquine in pregnant women with malaria.
    Fakeye TO; Fehintola FA; Ademowo OG; Walker O
    West Afr J Med; 2002; 21(4):286-7. PubMed ID: 12665265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid Chromatographic Methods for COVID-19 Drugs, Hydroxychloroquine and Chloroquine.
    Bilgin ZD; Evcil I; Yazgi D; Binay G; Okuyucu Genc C; Gulsen B; Huseynova A; Ozdemir AZ; Ozmen E; Usta Y; Ustun S; Caglar Andac S
    J Chromatogr Sci; 2021 Aug; 59(8):748-757. PubMed ID: 33336246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.